Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, Y. Articles by Winkler, M. E. Search for Related Content PubMed PubMed Citation Articles by Yang, Y. Articles by Winkler, M. E.

 Previous Article  |  Next Article 

Journal of Bacteriology, August 1998, p. 4294-4299, Vol. 180, No. 16
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Involvement of the gapA- and epd (gapB)-Encoded Dehydrogenases in Pyridoxal 5'-Phosphate Coenzyme Biosynthesis in Escherichia coli K-12

Yong Yang, Genshi Zhao, Tsz-Kwong Man, and Malcolm E. Winkler^*

Department of Microbiology and Molecular Genetics, University of Texas Houston Medical School, Houston, Texas 77030-1501

Received 9 April 1998/Accepted 12 June 1998

	ABSTRACT

Top Abstract Text References

We show that epd (gapB) mutants lacking an erythrose 4-phosphate (E4P) dehydrogenase are impaired for growth on some media and contain less pyridoxal 5'-phosphate (PLP) and pyridoxamine 5'-phosphate (PMP) than their epd⁺ parent. In contrast to a previous report, we found that gapA epd double mutants lacking the glyceraldehyde 3-phosphate and E4P dehydrogenases are auxotrophic for pyridoxine. These results implicate the GapA and Epd dehydrogenases in de novo PLP and PMP coenzyme biosynthesis.

	TEXT

Top Abstract Text References

Pyridoxal 5'-phosphate (PLP) is an essential coenzyme used by many enzymes involved in amino acid metabolism and by glycogen phosphorylases (reviewed in references 7, 12, and 16). PLP is thought to be synthesized in Escherichia coli by the convergence of two pathways (Fig. 1) (10, 18, 19, 25). The two branches lead to the synthesis of 4-phosphohydroxy-L-threonine (4PHT) and 1-deoxy-D-xylulose 5-phosphate, which are condensed by the PdxA and PdxJ enzymes to form pyridoxine 5'-phosphate (PNP) (Fig. 1) (6, 23). PNP is oxidized by the PdxH enzyme to form the active PLP coenzyme (24, 29, 39) (Fig. 1). PLP is converted to pyridoxamine 5'-phosphate (PMP) by the half-reaction of transaminases (4, 12) (Fig. 1). PMP is recycled back to PLP by the second half-reaction of transaminases and by PdxH oxidase (29, 39).

View larger version (25K): [in this window] [in a new window]   FIG. 1.   Pathway for PLP and PMP coenzyme biosynthesis in E. coli K-12. Enzymes that catalyze the steps in the pathway are indicated by their genetic symbols and are boxed. Branch 1 takes E4P to 4PHT, and branch 2 provides DXP, which is condensed with 4PHT to form PNP. PNP is oxidized to the active coenzyme PLP, which can be converted to PMP by transaminases. Oxidation of E4P to 4PE is the first step of branch 1 and is catalyzed by the E4P dehydrogenase activities of the GapA and Epd (GapB) enzymes. See text for details.

Overwhelming genetic and biochemical evidence implicate 4PHT as an obligatory intermediate that provides the phosphate ester group of PNP (13, 35, 37). 4PHT biosynthesis is thought to start with D-erythrose-4-phosphate (E4P), which is oxidized by an E4P dehydrogenase to 4-phosphoerythronate (4PE) (Fig. 1, branch 1). 4PE is further oxidized by the PdxB dehydrogenase and transaminated by the SerC (PdxF) enzyme to form 4PHT (Fig. 1). Three pieces of evidence support this scheme. First, tktA tktB double mutants, which lack transketolase activity and cannot synthesize E4P or the six aromatic amino acids and vitamins (Fig. 1), are pyridoxine (PN) auxotrophs (38). Second, purified PdxB enzyme oxidizes 4PE in a nonsustained reaction (36). Last, the SerC (PdxF) enzyme uses 4PHT as a substrate in the reverse transamination reaction (13). As expected from this scheme, pdxB and serC (pdxF) mutants are PN auxotrophs, but no single mutation that blocked the first E4P dehydrogenase step in branch 1 of the pathway was identified (10, 23).

Previous studies of epd (gapB). We proposed and confirmed that the gapB gene, which we renamed epd, encoded a nonphosphorylating E4P dehydrogenase (36). The E4P dehydrogenase activity of the Epd enzyme was verified by Boschi-Muller et al. (5), who further identified amino acids in Epd required for E4P dehydrogenase activity and showed that Epd has low-level phosphorylating and nonphosphorylating glyceraldehyde 3-phosphate (G3P) dehydrogenase activities in the presence and absence of inorganic phosphate, respectively. However, this G3P dehydrogenase activity is not sufficient to allow the growth of gapA mutants, which lack the major G3P dehydrogenase of E. coli (9, 20). Conversely, Boschi-Muller et al. showed that the GapA dehydrogenase of Bacillus stearothermophilus has a low level of phosphorylating E4P dehydrogenase activity, but this result was not extended to the E. coli GapA enzyme (5).

Recently Della Seta et al. (9) reported that E. coli gapB single and gapA gapB double mutants do not show a growth requirement for B₆ vitamers, such as PN and pyridoxal (PL), which can be converted to PLP and PMP by a salvage pathway (34, 35). If this finding were correct, then it would argue against a requirement for an E4P dehydrogenase in PLP biosynthesis (Fig. 1). We performed experiments similar to those of Della Seta et al. using what should be equivalent strains in three different E. coli genetic backgrounds. In contrast to their results, we found that gapA gapB mutants are indeed auxotrophic for B₆ vitamers and that gapB mutants are impaired for growth without PN under some growth conditions.

Construction of gapA and epd mutants. We moved the prototypic gapA1 point mutation of strain DF220 (20) by cotransduction with a linked Tn10 transposon into prototrophic strains W3110 and MG1655 grown in Luria-Bertani (LB) medium containing 1% (vol/vol) glycerol plus 1% (wt/vol) succinate (Table 1). The resulting MG1655 gapA1 mutant TX4125 had the expected phenotype of growth on plates containing minimal salts medium (MM) supplemented with glycerol plus succinate but no growth in 3 days on MM containing 0.4% (wt/vol) glucose (Table 2) (9, 20). The W3110 gapA1 mutant TX3484 grew very slowly on MM containing glucose, suggesting slight leakiness of the gapA1 mutation in some genetic backgrounds (Table 2); however, leakiness would not lead to the PN auxotrophy described below. Della Seta et al. mentioned low infectivity by P1 bacteriophage and spontaneous lysis of their gapA::Cm mutants (9); we did not encounter similar difficulties with gapA1 mutants.

View this table: [in this window] [in a new window]   TABLE 1.   Strains and plasmids

View this table: [in this window] [in a new window]   TABLE 2.   Growth deficiencies of gapA+ epd::(Cmr) and gapA1 epd::(Cmr) mutants on MM lacking PNa

We inserted an omega cassette imparting chloramphenicol resistance (Cm^r) into the single ClaI site of epd (gapB) and crossed the resulting epd::(Cm^r) mutation, which also contained a 4-bp deletion created during cloning, into the bacterial chromosome by transformation with linearized plasmid DNA (Fig. 2; Table 1) (2, 33). The epd::(Cm^r) mutation was crossed into the W3110 and MG1655 genetic backgrounds by generalized transduction (Table 1). Western immunoblotting showed that the Epd enzyme was expressed in the W3110 epd⁺ parent but not in the W3110 epd::(Cm^r) mutant (data not shown). The following G3P dehydrogenase-specific activities were obtained in crude extracts (36) of the W3110 gapA⁺ epd⁺, gapA⁺ epd::(Cm^r), gapA1 epd⁺, and gapA1 epd::(Cm^r) strains: 1,746 ± 53, 1,835 ± 117, 91 ± 4, and 0 nmol per min per mg of protein, respectively. Lack of or low residual G3P dehydrogenase activity in the gapA epd or gapA epd⁺ mutant, respectively, agrees with previous results (9).

View larger version (10K): [in this window] [in a new window]   FIG. 2.   Structure of the epd (gapB) gene (drawn to scale) at 66.17 min in the E. coli K-12 chromosome (1, 15, 21). epd (gapB) is surrounded by and oriented in the same direction as yggC, whose function is unknown, and pgk, which encodes the glycolytic enzyme phosphoglycerate kinase (1). Promoter mapping studies to be published elsewhere locate the promoters for epd (gapB) (Pepd) and pgk (Ppgk) in the regions indicated by bars. The location of the epd::(Cmr) insertion mutation constructed in this study (Table 1) is indicated. The epd::(Cmr) insertion mutation is upstream from the Ppgk promoter region and does not interfere with transcription of the pgk gene (data not shown).

Growth properties of gapA⁺ epd::(Cm^r) mutants. In contrast to the results of Della Seta et al. (9), we observed that colony formation of the gapA⁺ epd::(Cm^r) mutant was impaired on plates containing MM [Vogel-Bonner (1 × E) (8) or M63 (27)] supplemented with glycerol plus succinate or Casamino Acids as carbon sources (Table 2). This impaired growth was relieved by the addition of PN (Table 2) or glycolaldehyde (GA), which can be converted to 4PHT by an alternative pathway (14, 37). Growth of the gapA⁺ epd::(Cm^r) mutant was not significantly impaired on MM plates containing glucose, acetate, ribose, xylulose, fructose, or gluconic acid or in liquid medium containing glycerol plus succinate or Casamino Acids as carbon sources (Table 2 and data not shown).

We performed high-performance liquid chromatography (HPLC) (31) to confirm that the slower growth of the W3110 gapA⁺ epd::(Cm^r) mutant on MM plates containing glycerol plus succinate was correlated with reduced cellular levels of PLP and PMP (Fig. 3; Table 3). Of the six B₆ vitamers, we detected only PLP and PMP in stationary-phase cells washed from plates after 2 or 3 days and suspended and sonicated in cold 5% metaphosphoric acid (31). Consistent with the growth characteristics (Table 2), the W3110 gapA⁺ epd::(Cm^r) mutant contained only 64% of the PLP and PMP compared to the W3110 gapA⁺ epd⁺ parent, where most of the difference was a decrease in the amount of PMP (Table 3). Likewise, the W3110 gapA1 epd⁺ mutant contained only about 60% as much PMP as the parent; however, both strains contained equal amounts of PLP (Table 3). Finally, by assuming about 6 µl of water per mg of protein (28), we calculate that the stationary-phase W3110 gapA⁺ gapB⁺ parent contained about 76 and 36 µM PLP and PMP, respectively. These amounts are somewhat greater than the 40 µM combined intracellular concentration of PLP and PMP reported previously for E. coli K-12 (11). However, unlike this other report (11), we failed to detect appreciable B₆ vitamers excreted into the growth medium. Thus, the impaired growth of the gapA⁺ epd::(Cm^r) mutant was correlated with a 40% reduction in the amounts of cellular PLP and PMP.

View larger version (14K): [in this window] [in a new window]   FIG. 3.   HPLC chromatograms of B6 vitamers extracted from strains TX3470 (gapA+ epd+ parent) (top), TX3481 [(gapA+ epd::(Cmr)] (middle), and TX3484 (gapA1 epd+) (bottom). Strains were grown on plates as described in footnote a to Table 3, and B6 vitamers were partially purified by metaphosphoric acid and dichloromethane extractions and were resolved by reverse-phase, ion-pair HPLC on an Ultremex 3 C18 column (150 by 4.6 mm) (Phenomenex, Inc.) fitted with a guard column (30 by 4.6 mm) at 0.5 ml per min as described elsewhere (31). The tracings show the fluorescence intensity (excitation at 328 nm; emission at 393 nm) of postcolumn adducts between the B6 vitamers and sodium bisulfite (31). The elution positions and fluorescence yields of the six B6 vitamers (PLP, PMP, PNP, PL, PM, PN) were determined by using pure compounds as standards (data not shown). Only PLP and PMP (top panel) were detected in extracts of E. coli K-12. Two peaks that are not B6 vitamers were routinely detected (top panel) and were used along with protein amounts of the cells before extraction to normalize PLP and PMP amounts in different preparations. Amounts of PLP and PMP were determined (Table 3) by integration of peaks and comparison of areas with those of the PLP and PMP standard curves, which were linear over this range of concentrations. The fluorescence yield of the PMP-bisulfite adduct was approximately 5.6-fold greater than that of the PLP-bisulfite adduct (data not shown). This difference accounts for the fact that PLP peaks, which are apparently smaller than PMP peaks, actually correspond to more PLP than PMP (Fig. 3; Table 3).

View this table: [in this window] [in a new window]   TABLE 3.   Amounts of B6 vitamers in gapA+ epd+, gapA-1 epd+, and gapA+ epd::(Cmr) strains

PN auxotrophy of gapA epd double mutants. Most importantly, we found that the gapA1 epd::(Cm^r) double mutant was auxotrophic for PN on MM containing glycerol plus succinate (Table 2). After 2 days of incubation, we could not detect growth of the gapA1 epd::(Cm^r) double mutant, and after 3 days, we detected very small colonies which may have arisen by leakiness of the gapA1 point mutation. Growth was restored by the addition of PN or GA (Table 2). Unexpectedly, gapA1 mutants of MG1655 and W3110 grew on MM containing 0.4% sodium acetate as the carbon source (Table 2), whereas it was reported that the original DF220 gapA1 mutant in the K10 genetic background failed to grow on MM containing acetate (20). Nonetheless, the MG1655 and W3110 gapA1 gapB::(Cm^r) double mutants were again auxotrophic for PN on MM containing acetate (Table 2).

We confirmed the conclusion that gapA epd double mutants are auxotrophic for PN in one other way. We simply transduced the epd::(Cm^r) mutation into strain DF221 that contained the gapA2 nonsense allele (20), which is different from the gapA1 point mutation from strain DF220 used in the experiments described above (Table 1). Colonies of the resulting gapA2 epd::(Cm^r) double mutant TX4187 appeared on MM plates containing glycerol plus succinate and PN in 2 to 3 days; however, no colonies appeared after 5 days when PN was omitted from the growth medium (data not shown). DF221 (gapA-2) failed to grow on MM containing glucose after 3 days at 37°C, but it did grow on MM containing acetate (data not shown). These growth properties might be explained by slight leakiness of the gapA1 and gapA2 mutations such that there was sufficient gluconeogensis to allow growth on acetate but insufficient glycolysis to support growth on glucose. Finally, it could be argued that a mutation in another gene that cotransduces with the gapA1 point mutation caused the PN auxotrophy (Table 2). To rule out this hypothesis, we analyzed 20 independent spontaneous mutants of TX3491 and TX4134 [gapA1 epd::(Cm^r)] that grew rapidly as did the gapA⁺ epd::(Cm^r) strain on MM containing 0.4% (wt/vol) glucose. For all 20 mutants, reversion or suppression of the gapA1 mutation not only allowed growth on glucose medium but also alleviated the PN requirement.

Summary. Together, our data show that the GapA and Epd dehydrogenases are required for de novo PLP biosynthesis, and this involvement supports the pathway depicted in Fig. 1. The contribution of Epd dehydrogenase to 4PE synthesis seems to vary and becomes more significant in colonies growing on certain nonglycolytic carbon sources (Tables 2 and 3). We do not understand why the growth of gapA⁺ epd mutants is impaired on solid but not in liquid media (see above; Tables 2 and 3). In cells grown on glycolytic carbon sources, such as glucose, we observed that the specific activity of G3P dehydrogenase increased at least twofold in crude extracts compared to cells grown in MM containing glycerol plus succinate or acetate (data not shown). Therefore, it seems likely that the GapA enzyme alone is sufficient to carry out PLP biosynthesis in cells growing on glycolytic carbon sources. The involvement of the GapA enzyme in PLP biosynthesis is consistent with low levels of E4P dehydrogenase detected for some GapA dehydrogenases (5), and the enzymatic redundancy of GapA and Epd would explain why mutants deficient in this first step of branch 1 of PLP biosynthesis were never isolated (10, 23). Using purified enzymes, we did not detect feedback inhibition of the Epd E4P or GapA G3P dehydrogenase activities by 4PHT (data not shown). This finding is consistent with the idea that PLP biosynthesis responds to the carbon source and overall metabolic state instead of to the amounts of pathway end products (26).

We can only speculate as to why we obtained results completely different from those of Della Seta et al. (9). In their experiments, the parent and mutant strains seem to have been spread onto plates containing different combinations of antibiotics corresponding to the insertions in their gapA and epd mutants (9). However, it is not immediately clear why antibiotic addition would bypass the requirement for GapA and Epd in PLP biosynthesis. Likewise, it is difficult to see how polarity of the gapA and epd insertion mutations, if any, could bypass the need for an E4P dehydrogenase in PLP biosynthesis. In their experiments, no control was mentioned to test media for traces of B₆ vitamers that would allow growth of the gapA epd double mutant. Finally, it seems possible that their gapA epd (gapB) double mutant may have acquired a suppressor mutation that allowed growth without supplementation with B₆ vitamers. Another partial homolog of gapA, called gapC, is present in E. coli K-12, but gapC is not thought to encode a functional dehydrogenase (5, 17).

	ACKNOWLEDGMENTS

We thank D. G. Fraenkel, H. M. Krisch, C. A. Gross, A. J. Clark, and C. Yanofsky for the strains and plasmids used in this study and members of this laboratory for helpful discussions and critical comments.

This work was supported by Public Health Services grant RO1-GM37561 from the National Institute of General Medical Sciences.

Yong Yang and Genshi Zhao contributed equally to this work.

	FOOTNOTES

^* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics, University of Texas Houston Medical School, 6431 Fannin; JFB 1.765, Houston, TX 77030-1501. Phone: (713) 500-5461. Fax: (713) 500-5499. E-mail: mwinkler{at}utmmg.med.uth.tmc.edu.

Present address: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285-0438.

	REFERENCES

Top Abstract Text References

1.	Alefounder, P. R., and R. N. Perham. 1989. Identification, molecular cloning and sequence analysis of a gene cluster encoding the class II fructose 1,6-bisphosphate aldolase, 3-phosphoglycerate kinase and a putative second glyceraldehyde 3-phosphate dehydrogenase of Escherichia coli. Mol. Microbiol. 3:723-732[Medline].
2.	Arps, P. J., and M. E. Winkler. 1987. Structural analysis of the Escherichia coli K-12 hisT operon by using a kanamycin resistance cassette. J. Bacteriol. 169:1061-1070[Abstract/Free Full Text].
3.	Bachmann, B. J. 1987. Derivatives and genotypes of some mutant derivatives of Escherichia coli K-12, p. 1190-1219. In F. C. Neidhardt, J. L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology, vol. 2. ASM Press, Washington, D.C.
4.	Bender, D. A. 1985. Amino acid metabolism. John Wiley & Sons, New York, N.Y.
5.	Boschi-Muller, S., S. Azza, D. Pollastro, C. Corbier, and G. Branlant. 1997. Comparative enzymatic properties of GapB-encoded erythrose-4-phosphate dehydrogenase of Escherichia coli and phosphorylating glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 272:15106-15112[Abstract/Free Full Text].
6.	Cane, D. E., Y. Hsiung, J. A. Cornish, J. K. Robinson, and I. D. Spenser. 1998. Biosynthesis of vitamin B6: the oxidation of 4-(phosphohydroxy)-L-threonine by PdxA. J. Am. Chem. Soc. 120:1936-1937.
7.	Dakshinamurti, K. (ed.). 1990. Vitamin B6. Ann. N. Y. Acad. Sci., vol. 585. .
8.	Davis, R. W., D. Botstein, and J. R. Roth. 1980. Advanced bacterial genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
9.	Della Seta, F., S. Boschi-Muller, M. L. Vignais, and G. Branlant. 1997. Characterization of Escherichia coli strains with gapA and gapB genes deleted. J. Bacteriol. 179:5218-5221[Abstract/Free Full Text].
10.	Dempsey, W. B. 1987. Synthesis of pyridoxal phosphate, p. 539-543. In F. C. Neidhardt, J. L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology, vol. 1. ASM Press, Washington, D.C.
11.	Dempsey, W. B., and L. J. Arcement. 1971. Identification of the forms of vitamin B6 present in the culture media of "vitamin B6 control" mutants. J. Bacteriol. 107:580-582[Abstract/Free Full Text].
12.	Dolphin, D., R. Poulson, and O. Avramovic. 1986. Vitamin B6 pyridoxal phosphate: chemical, biochemical, and medical Aspects. Wiley Interscience, New York, N.Y.
13.	Drewke, C., M. Klein, D. Clade, A. Arenz, R. Muller, and E. Leistner. 1996. 4-O-Phosphoryl-L-threonine, a substrate of the pdxC(serC) gene product involved in vitamin B6 biosynthesis. FEBS Lett. 390:179-182[Medline].
14.	Drewke, C., C. Notheis, U. Hansen, E. Leistner, T. Hemscheidt, R. E. Hill, and I. D. Spenser. 1993. Growth response to 4-hydroxy-L-threonine of Escherichia coli mutants blocked in vitamin B6 biosynthesis. FEBS Lett. 318:125-128[Medline].
15.	Fraenkel, D. G. 1996. Glycolysis, p. 189-198. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C.
16.	Helmreich, E. J. 1992. How pyridoxal 5'-phosphate could function in glycogen phosphorylase catalysis. Biofactors 3:159-172[Medline].
17.	Hidalgo, E., A. Limon, and J. Aguilar. 1996. A second Escherichia coli gene with similarity to gapA. Microbiologia 12:99-106[Medline].
18.	Hill, R. E., K. Himmeldirk, I. A. Kennedy, R. M. Pauloski, B. G. Sayer, E. Wolf, and I. D. Spenser. 1996. The biogenetic anatomy of vitamin B6: a 13C NMR investigation of the biosynthesis of pyridoxol in Escherichia coli. J. Biol. Chem. 271:30426-30435[Abstract/Free Full Text].
19.	Hill, R. E., and I. D. Spenser. 1996. Biosynthesis of vitamin B6, p. 695-703. In F. C. Neidhardt, R. Curtiss, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed, vol. 1. ASM Press, Washington, D.C.
20.	Hillman, J. D., and D. G. Fraenkel. 1975. Glyceraldehyde 3-phosphate dehydrogenase mutants of Escherichia coli. J. Bacteriol. 122:1175-1179[Abstract/Free Full Text].
21.	Irani, M. H., and P. K. Maitra. 1976. Glyceraldehyde-3-P dehydrogenase, glycerate-3-P kinase and enolase mutants of Escherichia coli: genetic studies. Mol. Gen. Genet. 145:65-71[Medline].
22.	Kushner, S. R., H. Nagaishi, and A. J. Clark. 1972. Indirect suppression of recB and recC mutations by exonuclease I deficiency. Proc. Natl. Acad. Sci. USA 69:1366-1370[Abstract/Free Full Text].
23.	Lam, H. M., E. Tancula, W. B. Dempsey, and M. E. Winkler. 1992. Suppression of insertions in the complex pdxJ operon of Escherichia coli K-12 by lon and other mutations. J. Bacteriol. 174:1554-1567[Abstract/Free Full Text].
24.	Lam, H. M., and M. E. Winkler. 1992. Characterization of the complex pdxH-tyrS operon of Escherichia coli K-12 and pleiotropic phenotypes caused by pdxH insertion mutations. J. Bacteriol. 174:6033-6045[Abstract/Free Full Text].
25.	Lam, H. M., and M. E. Winkler. 1990. Metabolic relationships between pyridoxine (vitamin B6) and serine biosynthesis in Escherichia coli K-12. J. Bacteriol. 172:6518-6528[Abstract/Free Full Text].
26.	Man, T.-K., A. J. Pease, and M. E. Winkler. 1997. Maximization of transcription of the serC (pdxF)-aroA multifunctional operon by antagonistic effects of the cyclic AMP (cAMP) receptor protein-cAMP complex and Lrp global regulators of Escherichia coli K-12. J. Bacteriol. 179:3458-3469[Abstract/Free Full Text].
27.	Miller, J. H. 1992. A short course in bacterial genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
28.	Moat, A. G., and J. W. Foster. 1995. Introduction to microbial physiology, p. 1-27. , Microbial physiology, 3rd ed. Wiley-Liss, Inc., New York, N.Y.
29.	Notheis, C., C. Drewke, and E. Leistner. 1995. Purification and characterization of the pyridoxal 5'-phosphate: oxygen oxidoreductase (deaminating) from Escherichia coli. Biochim. Biophys. Acta 1247:265-271[Medline].
30.	Prentki, P., and H. M. Krisch. 1984. In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29:303-313[Medline].
31.	Sharma, S. K., and K. Dakshinamurti. 1992. Determination of vitamin B6 vitamers and pyridoxic acid in biological samples. J. Chromatogr. 578:45-51[Medline].
32.	Singer, M., G. Baker, G. Schnitzler, S. M. Deischel, M. Goel, W. Dove, K. J. Jaacks, A. D. Grossman, J. W. Erickson, and C. A. Gross. 1989. A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli. Microbiol. Rev. 53:1-24[Abstract/Free Full Text].
33.	Winans, S., S. J. Elledge, J. H. Krueger, and G. C. Walker. 1985. Site-directed insertion and deletion mutagenesis with cloned fragments in Escherichia coli. J. Bacteriol. 161:1219-1221[Abstract/Free Full Text].
34.	Yang, Y., H.-C. T. Tsui, T.-K. Man, and M. E. Winkler. 1998. Identification and function of the pdxY gene, which encodes a novel pyridoxal kinase involved in the salvage pathway of pyridoxal 5'-phosphate biosynthesis in Escherichia coli K-12. J. Bacteriol. 180:1814-1821[Abstract/Free Full Text].
35.	Yang, Y., G. Zhao, and M. E. Winkler. 1996. Identification of the pdxK gene that encodes pyridoxine (vitamin B6) kinase in Escherichia coli K-12. FEMS Microbiol. Lett. 141:89-95[Medline].
36.	Zhao, G., A. J. Pease, N. Bharani, and M. E. Winkler. 1995. Biochemical characterization of gapB-encoded erythrose 4-phosphate dehydrogenase of Escherichia coli K-12 and its possible role in pyridoxal 5'-phosphate biosynthesis. J. Bacteriol. 177:2804-2812[Abstract/Free Full Text].
37.	Zhao, G., and M. E. Winkler. 1996. 4-Phospho-hydroxy-L-threonine is an obligatory intermediate in pyridoxal 5'-phosphate coenzyme biosynthesis in Escherichia coli K-12. FEMS Microbiol. Lett. 135:275-280[Medline].
38.	Zhao, G., and M. E. Winkler. 1994. An Escherichia coli K-12 tktA tktB mutant deficient in transketolase activity requires pyridoxine (vitamin B6) as well as the aromatic amino acids and vitamins for growth. J. Bacteriol. 176:6134-6138[Abstract/Free Full Text].
39.	Zhao, G., and M. E. Winkler. 1995. Kinetic limitation and cellular amount of pyridoxine (pyridoxamine) 5'-phosphate oxidase of Escherichia coli K-12. J. Bacteriol. 177:883-891[Abstract/Free Full Text].

---

Journal of Bacteriology, August 1998, p. 4294-4299, Vol. 180, No. 16
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

This article has been cited by other articles:

• Craig, J. P., Bekal, S., Hudson, M., Domier, L., Niblack, T., Lambert, K. N. (2008). Analysis of a Horizontally Transferred Pathway Involved in Vitamin B6 Biosynthesis from the Soybean Cyst Nematode Heterodera glycines. Mol Biol Evol 25: 2085-2098 [Abstract] [Full Text]  
• Raschle, T., Arigoni, D., Brunisholz, R., Rechsteiner, H., Amrhein, N., Fitzpatrick, T. B. (2007). Reaction Mechanism of Pyridoxal 5'-Phosphate Synthase: DETECTION OF AN ENZYME-BOUND CHROMOPHORIC INTERMEDIATE. J. Biol. Chem. 282: 6098-6105 [Abstract] [Full Text]  
• Tazoe, M., Ichikawa, K., Hoshino, T. (2006). Flavin Adenine Dinucleotide-Dependent 4-Phospho-D-Erythronate Dehydrogenase Is Responsible for the 4-Phosphohydroxy-L-Threonine Pathway in Vitamin B6 Biosynthesis in Sinorhizobium meliloti. J. Bacteriol. 188: 4635-4645 [Abstract] [Full Text]  
• Wrenger, C., Eschbach, M.-L., Muller, I. B., Warnecke, D., Walter, R. D. (2005). Analysis of the Vitamin B6 Biosynthesis Pathway in the Human Malaria Parasite Plasmodium falciparum. J. Biol. Chem. 280: 5242-5248 [Abstract] [Full Text]  
• Tanaka, T., Tateno, Y., Gojobori, T. (2005). Evolution of Vitamin B6 (Pyridoxine) Metabolism by Gain and Loss of Genes. Mol Biol Evol 22: 243-250 [Abstract] [Full Text]  
• Sivaraman, J., Li, Y., Banks, J., Cane, D. E., Matte, A., Cygler, M. (2003). Crystal Structure of Escherichia coli PdxA, an Enzyme Involved in the Pyridoxal Phosphate Biosynthesis Pathway. J. Biol. Chem. 278: 43682-43690 [Abstract] [Full Text]  
• Ehrenshaft, M., Daub, M. E. (2001). Isolation of PDX2, a Second Novel Gene in the Pyridoxine Biosynthesis Pathway of Eukaryotes, Archaebacteria, and a Subset of Eubacteria. J. Bacteriol. 183: 3383-3390 [Abstract] [Full Text]  
• Ehrenshaft, M., Bilski, P., Li, M. Y., Chignell, C. F., Daub, M. E. (1999). A highly conserved sequence is a novel gene involved in de novo vitamin B6 biosynthesis. Proc. Natl. Acad. Sci. USA 96: 9374-9378 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, Y. Articles by Winkler, M. E. Search for Related Content PubMed PubMed Citation Articles by Yang, Y. Articles by Winkler, M. E.